Cargando…

Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity

PURPOSE: We aimed to identify the risk factors that may predispose preterm neonates to develop aggressive posterior retinopathy of prematurity (APROP). METHODS: This retrospective case control study included 16 infants with APROP in zone 1 or posterior zone 2. Thirty-four gestational age and birth w...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel Salam Gomaa, Nancy, Helmy, Youssef A H, Maher, Sara, Hassanein, Dina, Shuaib, Asmaa, Hegazy, Ahmed I, Ali, Aliaa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179817/
https://www.ncbi.nlm.nih.gov/pubmed/34103890
http://dx.doi.org/10.2147/OPTH.S292712
_version_ 1783703869231988736
author Abdel Salam Gomaa, Nancy
Helmy, Youssef A H
Maher, Sara
Hassanein, Dina
Shuaib, Asmaa
Hegazy, Ahmed I
Ali, Aliaa A
author_facet Abdel Salam Gomaa, Nancy
Helmy, Youssef A H
Maher, Sara
Hassanein, Dina
Shuaib, Asmaa
Hegazy, Ahmed I
Ali, Aliaa A
author_sort Abdel Salam Gomaa, Nancy
collection PubMed
description PURPOSE: We aimed to identify the risk factors that may predispose preterm neonates to develop aggressive posterior retinopathy of prematurity (APROP). METHODS: This retrospective case control study included 16 infants with APROP in zone 1 or posterior zone 2. Thirty-four gestational age and birth weight-matched controls with stage 2 or less ROP were included. We reviewed medical records on infant birth and postnatal characteristics. RESULTS: Patients who developed APROP had a significantly longer duration of caffeine therapy, were significantly more likely to be small for gestational age (SGA), and were more likely to have a positive blood culture than patients who developed less severe ROP. Patients with APROP who required retreatment had received inotropes for a longer duration of time, had received more plasma transfusions, were more likely to have IVH, and had a greater decrease in the serum hemoglobin during hospitalization. CONCLUSION: Being SGA, receiving caffeine for a longer duration, and having culture-proven sepsis were associated with APROP. IVH, a low serum hemoglobin, the need for more plasma transfusions, and a longer duration of inotropes were associated with APROP which required retreatment.
format Online
Article
Text
id pubmed-8179817
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81798172021-06-07 Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity Abdel Salam Gomaa, Nancy Helmy, Youssef A H Maher, Sara Hassanein, Dina Shuaib, Asmaa Hegazy, Ahmed I Ali, Aliaa A Clin Ophthalmol Original Research PURPOSE: We aimed to identify the risk factors that may predispose preterm neonates to develop aggressive posterior retinopathy of prematurity (APROP). METHODS: This retrospective case control study included 16 infants with APROP in zone 1 or posterior zone 2. Thirty-four gestational age and birth weight-matched controls with stage 2 or less ROP were included. We reviewed medical records on infant birth and postnatal characteristics. RESULTS: Patients who developed APROP had a significantly longer duration of caffeine therapy, were significantly more likely to be small for gestational age (SGA), and were more likely to have a positive blood culture than patients who developed less severe ROP. Patients with APROP who required retreatment had received inotropes for a longer duration of time, had received more plasma transfusions, were more likely to have IVH, and had a greater decrease in the serum hemoglobin during hospitalization. CONCLUSION: Being SGA, receiving caffeine for a longer duration, and having culture-proven sepsis were associated with APROP. IVH, a low serum hemoglobin, the need for more plasma transfusions, and a longer duration of inotropes were associated with APROP which required retreatment. Dove 2021-06-01 /pmc/articles/PMC8179817/ /pubmed/34103890 http://dx.doi.org/10.2147/OPTH.S292712 Text en © 2021 Abdel Salam Gomaa et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Abdel Salam Gomaa, Nancy
Helmy, Youssef A H
Maher, Sara
Hassanein, Dina
Shuaib, Asmaa
Hegazy, Ahmed I
Ali, Aliaa A
Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
title Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
title_full Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
title_fullStr Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
title_full_unstemmed Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
title_short Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
title_sort clinical characteristics of preterm neonates with aggressive posterior retinopathy of prematurity
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179817/
https://www.ncbi.nlm.nih.gov/pubmed/34103890
http://dx.doi.org/10.2147/OPTH.S292712
work_keys_str_mv AT abdelsalamgomaanancy clinicalcharacteristicsofpretermneonateswithaggressiveposteriorretinopathyofprematurity
AT helmyyoussefah clinicalcharacteristicsofpretermneonateswithaggressiveposteriorretinopathyofprematurity
AT mahersara clinicalcharacteristicsofpretermneonateswithaggressiveposteriorretinopathyofprematurity
AT hassaneindina clinicalcharacteristicsofpretermneonateswithaggressiveposteriorretinopathyofprematurity
AT shuaibasmaa clinicalcharacteristicsofpretermneonateswithaggressiveposteriorretinopathyofprematurity
AT hegazyahmedi clinicalcharacteristicsofpretermneonateswithaggressiveposteriorretinopathyofprematurity
AT alialiaaa clinicalcharacteristicsofpretermneonateswithaggressiveposteriorretinopathyofprematurity